English

国際会議

国際会議


第6回 国際交流フォーラム

会 長 渡辺 純夫(順天堂大学医学部消化器内科,第103回総会会長)
会 期 2017年4月20日(木) 08:50-16:46
会 場 京王プラザホテル(第103回総会会場) 南館4階 「錦」
内 容 Main Theme:NASH

Opening Remarks
Sumio Watanabe(Dept. of Gastroenterology, Juntendo Univ. School of Medicine, Japan)

1.The Epidemiology and Natural History of NASH
Moderators:
Yoichi Hiasa(Dept. of Gastroenterology and Metabology, Ehime Univ. Graduate School of Medicine, Japan)
Brent A Neuschwander-Tetri(Saint Louis Univ., USA)

IF1-1[Keynote Lecture]
Recent trend in NAFLD/NASH in Asia Pacific region

Kenichi Ikejima(Dept. of Gastroenterology, Juntendo Univ. School of Medicine, Japan)

IF1-2 Characteristics of Japanese NAFLD/NASH
Masafumi Ono(Dept. of Gastroenterology and Hepatology, Kochi Medical School, Japan)

IF1-3 Progression and its risk factors in NASH/NAFLD
Katsutoshi Tokushige(Dept. of Internal Medicine and Gastroenterology, Tokyo Women’s Medical Univ., Japan)

IF1-4 The Epidemiology and Natural History of NASH
Ayano Inui(Dept. of Pediatric Hepatology and Gastroenterology, Saiseikai Yokohamashi Tobu Hospital, Japan)

2.Pathophysiology of NASH
Moderators:
Goshi Shiota(Dept. of Genetic Medicine and Regenerative Therapeutics, Tottori Univ., Japan)
David A. Brenner(Univ. of California, San Diego, USA)

IF2-1[Keynote Lecture]
NADPH Oxidases in NASH

Natalie J Torok(Dept. of Internal Medicine, Gastroenterology and Hepatology, UC Davis, USA)

IF2-2 Significance of Hepatocyte Lipotoxicity in NAFLD/NASH:How the free fatty acid mediated Signals Kill and tell
Yuko Akazawa(Dept. of Pathology, Nagasaki Univ. School of Medicine, Japan)

IF2-3 The impairment of autophagic function is involved in the progression of non alcoholic fatty liver disease
Shunhei Yamashina(Dept. of Gastroenterology, Juntendo Univ. School of Medicine, Japan)

IF2-4 The role of IL 17 in progression of NASH to HCC.
Tatiana Kisseleva(Dept. of Surgery, Univ. of California, San Diego, USA)

3.Diagnosis of NASH
Moderators:
Shuji Terai(Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata Univ., Japan)
David E Kleiner(Laboratory of Pathology National Cancer Institute, USA)

IF3-1[Keynote Lecture]
Histopathology of Fatty Liver Disease in Adults and Children

David E Kleiner(Laboratory of Pathology, National Cancer Institute, USA)

IF3-2 Pathological features of NAFLD/NASH
Michiie Sakamoto(Dept. of Pathology, Keio Univ. School of Medicine, Japan)

IF3-3 MR elastography of the liver for staging liver fibrosis
Utaroh Motosugi(Dept. of Radiology, Univ. of Yamanashi, Japan)

IF3-4 Biomarkers for NAFLD/NASH
Yoshihiro Kamada(Dept. of Molecular Biochemistry & Clinical Investigation, Osaka Univ., Graduate School of Medicine, Japan)

IF3-5 Exosomal microRNAs as novel biomarker for HCC
Yong Han Paik(Dept. of Medicine, Samsung Medical Center, Sungkyunkwan Univ. School of Medicine, Korea)

4.Treatment of NASH:from basic to clinical
Moderators:
Toshiji Saibara(Kochi Medical School, Kochi Univ., Japan)
Natalie J. Torok(Dept. of Internal Medicine, Gastroenterology and Hepatology, UC Davis, USA)

IF4-1[Keynote Lecture]
The treatment of NASH based our current understanding of its pathophysiology

Brent A Neuschwander Tetri(Saint Louis Univ., USA)

IF4-2 Lifestyle interventions for NAFLD/NASH
Yuichiro Eguchi(Liver Center, Saga Univ., Japan)

IF4-3 Current pharmacological therapies for NAFLD/NASH
Masashi Yoneda(Division of Gastroenterology and Hepatology, Dept. of Internal Medicine, Aichi Medical Univ., Japan)

IF4-4 Non invasive diagnostic tools for NAFLD
Atsushi Nakajima(Yokohama City Univ. Graduate School of Medicine, Japan)

Special Remarks
Takeshi Okanoue(Saiseikai Suita Hospital, Japan)

Closing Remarks
Sumio Watanabe(Dept. of Gastroenterology, Juntendo Univ. School of Medicine, Japan)
参加費 無料
参加方法 当日受付


第12回 JSGE-AGA Joint Meeting

会 長 木下 芳一(島根大学医学部第2内科,国際委員会担当理事)
会 期 2017年4月20日(木) 14:20-16:50
会 場 京王プラザホテル(第103回総会会場) 本館42階 「高尾」
内 容 Main Theme:Eosinophilic Esophagitis and Gastroenteritis
Moderators:
Evan S. Dellon(Center for Esopahgeal Diseases and Swallowing, Division of Gastronterology and Hepatology, Univ. of North Carolina School of Medicine, USA)
Yoshikazu Kinoshita(Shimane Univ. School of Medicine, Japan)

Opening Remarks
Yoshikazu Kinoshita(Shimane Univ. School of Medicine, Japan)

JA-1 Epidemiology, diagnosis and treatment of eosinophilic esophagitis in the USA
Evan S. Dellon(Center for Esopahgeal Diseases and Swallowing, Division of Gastronterology and Hepatology, Univ. of North Carolina School of Medicine, USA)

JA-2 Eosinophilic Esophagitis―Recent Research Progress
Joan Weichun Chen(Division of Gastroenterology and Hepatology, Dept. of Internal Medicine, Univ. of Michigan, USA)

JA-3 Diagnosis and treatment of eosinophilic esophagitis:current status in Japan
Norihisa Ishimura(Dept. of Gastroenterology and Hepatology, Shimane Univ. School of Medicine, Japan)

JA-4 Eosinophilic Gastroenteritis(EGE)
Ichiro Nomura(Dept. of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Japan)

Closing Remarks
Evan S. Dellon(Center for Esopahgeal Diseases and Swallowing, Division of Gastronterology and Hepatology, Univ. of North Carolina School of Medicine, USA)
参加費 無料
参加方法 当日受付


第1回 アジアンセッション(JSGE and KSG joint session)

会 長 岡崎 和一(関西医科大学内科学第3講座,アジアとの国際協力推進委員会担当理事)
会 期 2017年4月21日(金) 08:30-11:00
会 場 京王プラザホテル(第103回総会会場) 南館3階 「グレース」
内 容 Main Theme:Immunology and Digestive Organs
Moderators:
Kazuichi Okazaki(Dept. of Gastroenterology and Hepatology, Kansai Medical Univ., Japan)
Sumiko Nagoshi(Dept. of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical Univ., Japan)
Dong Wan Seo(Dept. of Gastroenterology, Univ. Ulsan College of Medicine, Asan Medical Center, Korea)

Opening Remarks
Tooru Shimosegawa(Division of Gastroenterology, Tohoku Univ. Graduate School of Medicine, Japan)

AS-1 Update of Immunological Aspects in Digestive Organs
Atsushi Mizoguchi(Dept. of Immunology, Kurume Univ. School of Medicine, Japan)

AS-2 Role of PD 1, CTLA 4 and FoxP3 in Viral Hepatitis
Chang Wook Kim(Division of Gastroenterology and Hepatology, Dept. of Internal Medicine, College of Medicine, The Catholic Univ. of Korea, Korea)

AS-3 Immune responses in primary biliary cholangitis
Shinji Shimoda(Clinical Education Center, Kyushu Univ. Hospital, Japan)

AS-4 Clinical Approach according to the Differential Diagnosis of AIP
Ji Kon Ryu(Dept. of Internal Medicine and Liver Research Institute, Seoul National Univ. College of Medicine, Korea)

AS-5 Immunological Aspects in Type1 Autoimmune Pancreatitis
Kazushige Uchida(Dept. of Gastroenterology and Hepatology, Kansai Medical Univ., Japan)

Closing Remarks
Sang Woo Lee(Korea Univ. College of Medicine, Korea)
参加費 無料
参加方法 当日受付


第4回 International Topic Conference

会 長 木下 芳一(島根大学第2内科,国際委員会担当理事)
副会長 大草 敏史(東京慈恵会医科大学附属柏病院消化器・肝臓内科,学術集会検討委員会副委員長)
実行委員 金井 隆典(慶應義塾大学医学部内科学(消化器))
長田 太郎(順天堂大学医学部附属順天堂医院消化器内科)
中本 伸宏(慶應義塾大学医学部消化器内科)
会 期 2017年4月21日(金) 14:20-16:50
会 場 京王プラザホテル(第103回総会会場) 南館3階 「グレース」
内 容 Main Theme:Microbiota in Gastrointestinal and liver diseases
Moderators:
Nobuhiro Nakamoto(Division of Gastroenterology, Keio Univ. School of Medicine, Japan)
Bernd Schnabl(Dept. of Medicine, Univ. of California San Diego, USA)

IT-1 The role of gut microbiota and metabolome in nonalcoholic fatty liver disease
Takaomi Kessoku(Dept. of Gastroenterology and Hepatology, Yokohama City Univ. Graduate School of Medicine, Japan)

IT-2 Gut microbiota promotes obesity associated liver cancer development: a collaborative role of lipoteichoic acid and deoxycholic acid
Naoko Ohtani(Dept. of Physiology, Osaka City Univ. Graduate School of Medicine, Japan)

IT-3 Host Microbiota Interactions in Liver Diseases
Bernd Schnabl(Dept. of Medicine, Univ. of California San Diego, USA)
Moderators:
Shuji Ogino(Division of MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital, Dana Farber Cancer Institute, Harvard Medical School, and Harvard T.H. Chan School of Public Health, USA)
Taro Osada(Dept. of Gastroenterology, Juntendo Univ. School of Medicine, Japan)

IT-4 Emerging Microbial , Immuno , and Pharmaco MPE(Molecular Pathological Epidemiology)for Precision Medicine
Shuji Ogino(Division of MPE Molecular Pathological Epidemiology, Brigham and Women’s Hospital, Dana Farber Cancer Institute, Harvard Medical School, and Harvard T.H. Chan School of Public Health, USA)

IT-5 Fecal transplantation for patients with ulcerative colitis;microbial shifts and signatures of long term remission after treatment
Noortje G Rossen(Dept. of Gastroenterology and Hepatology, Academic Medical Center, the Netherlands)

IT-6 Comprehensive bacteriotherapy:combination with fecal microbial transplantation and antibiotics for ulcerative colitis
Dai Ishikawa(Dept. of Gastroenterology, Juntendo Univ. School of Medicine, Japan)
参加費 無料
参加方法 当日受付


第8回 Asian Pacific Topic Conference

会 期 2017年5月22日(月)
会 場 The Stones Hotel – Bali, Indonesia
内 容 第8回APTCは、インドネシアのDigestive Disease Week 2017内で開催されます。
詳細については、第8回APTCホームページをご参照下さい。

ページトップへ